ANANDA Scientific Debuts Beverage-Stable CBD Formulation

ANANDA Scientific, a clinical-stage biotech company pioneering patented delivery technologies for cannabinoids and other plant-derived compounds, today announced the launch of a new science-based breakthrough for effective delivery of CBD in beverages. This new water-stable formulation of ANANDA’s patented, high-bioavailability Liquid Structure™ CBD corrects many of the shortfalls of CBD beverage products currently on the market. 

“ANANDA’s innovative patented delivery technology (United States Patents 7,182,950 and 10.149,824) presents tremendous new opportunity for worldwide expansion of the CBD beverage sector,” said Mark J. Rosenfeld, M.S., Ph.D., Chief Executive Officer and Chief Science Officer. “We are excited to be paving the way through sound science with the first high-bioavailability cannabinoid formulation that stays in solution and otherwise remains stable at all ends of the supply chain.” 

CBD falls irretrievably out of most aqueous mixtures in a matter of a few hours or days.

Consequently, CBD beverage products on the market claiming to be water-soluble and bioavailable oftentimes fail to effectively deliver a useful product, particularly when housed in aluminum cans, as showcased in the Cannabis & Tech Today article “This Issue Might Limit the Popularity of Canned Cannabis Drinks.” Novel solutions like those from ANANDA Scientific are needed to correct this deficiency and become more so important to make certain that CBD efficiently enters the bloodstream more rapidly and in larger amounts than oil-based infusion formulas on the market, as noted in the Visual Capitalist article “Visualizing the Boom in the CBD Beverage Market.” ANANDA Scientific’s new product does that with real scientific data showing this to be the case.

“Liquids infused by liposomal and nano-emulsion technologies, especially those using fat-based chemistry, tend to be unstable whereby the CBD irretrievably adheres to the sides of plastic, glass and aluminum containers, which critically impacts the efficacy of the CBD originally added to the solution,” said Mark Coffie, ANANDA’s Chief Business Development Officer. “Our high-bioavailability Liquid Structure™ formulation offers the technology to deliver cannabis-infused beverages to market in plastic, glass and aluminum packaging without affecting the potency of the liquid for broader, more cost-effective distribution.”

ABOUT ANANDA SCIENTIFIC

ANANDA is a research-focused biotech company that employs patented delivery technologies to make cannabinoids and other plant-derived compounds highly bioavailable, water-soluble and shelf-life-stable in nutraceutical and pharmaceutical products. ANANDA is pursuing clinical trials for pharmaceutical approval that use its technology to address therapeutic targets of tremendous public health importance. On the back of its strong research base, the company has a growing pipeline of nutraceutical over-the-counter products. The company has successfully launched these in the U.S., U.K. and EU, with expansion into China, Australia and Africa planned for the near future. The company is expanding its research base through multiple sponsored research agreements with universities to diversify its technology footprint.

Contact for ANANDA Scientific:

ANANDA Scientific Media Relations
Media Inquiries
303-317-5551
​Email: [email protected]

Source: ANANDA Scientific

Share:


Tags: alternative medicine, biotech, cannabinoid, cannabis, CBD, healthcare, medical news, medical research, nutraceuticals, nutritional supplement, pharmaceuticals